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Abstract
We investigated the diagnostic capabilities of I-131, Tl-201, and Tc-99m-MIBI (hexakis-2-
methoxyisobutyl- isonitrile) scintigraphy for thyroid cancer metastases after total thyroidectomy
over the entire body and for every locus before and after thyroid bed ablation. After total thyroidec-
tomy of thyroid cancer, 36 cases were subjected to I-131 treatment 64 times. They consisted of 17
men and 19 women with 31 papillary carcinomas and 5 follicular carcinomas. Their ages were 22–
75(an average of 60.5+/-12.3) years. I-131 scintigraphy(I-131), Tl-201 scintigraphy(Tl-201), and
Tc-99m- MIBI scintigraphy (Tc-99m-MIBI) were performed. We defined the metastases as those
cases in which serum thyroglobulin (Tg)increased significantly or in which we were able to prove
the lesions on CT (computed tomography), MRI (magnetic resonance imaging) or bone scinti-
gram. Three radiology medical specialists visually evaluated each scintigram and calculated the
sensitivity, specificity, and likelihood ratio. For whole-body sensitivity, both Tl-201 and Tc-99m-
MIBI were high before ablation and I-131 was high after ablation. Before ablation, the negative
likelihood ratio was less than 0.1 for Tl-201 and Tc-99m-MIBI, while the positive likelihood ratio
was more than 10 for Tl-201. After ablation, the positive likelihood ratio for I-131, Tl-201, and
Tc-99m-MIBI was more than 10. The sensitivity of the mediastinum was appropriate, except for
I-131 before ablation, and the sensitivity of the lung before and after ablation was inferior for ei-
ther tracer. The specificity of the cervix for I-131 before ablation was markedly deteriorated, but
it increased after ablation.
KEYWORDS: I-131scintigraphy, Tl-201 scintigraphy, Tc-99m-MIBI scintigraphy, thyroid can-
cer metastases
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We investigated the diagnostic capabilities of I-131, Tl-201, and Tc-99m-MIBI (hexakis-2-methoxy-
isobutyl-isonitrile) scintigraphy for thyroid cancer metastases after total thyroidectomy over the entire body and for every locus before and after thyroid bed ablation. After total thyroidectomy of thyroid cancer, 36 cases were subjected to I-131 treatment 64 times. They consisted of 17 men and 19 women with 31 papillary carcinomas and 5 follicular carcinomas. Their ages were 22-75 (an average of 60.5±12.3)years. I-131 scintigraphy(I-131), Tl-201 scintigraphy(Tl-201), and Tc-99m-
MIBI scintigraphy(Tc-99m-MIBI)were performed. We deﬁned the metastases as those cases in which serum thyroglobulin (Tg)increased signiﬁcantly or in which we were able to prove the lesions on CT (computed tomography), MRI (magnetic resonance imaging) or bone scintigram. Three radiology medical specialists visually evaluated each scintigram and calculated the sensitivity,
speciﬁcity, and likelihood ratio. For whole-body sensitivity, both Tl-201 and Tc-99m-MIBI were high before ablation and I-131 was high after ablation. Before ablation, the negative likelihood ratio was less than 0.1 for Tl-201 and Tc-99m-MIBI, while the positive likelihood ratio was more than 10 for Tl-201. After ablation, the positive likelihood ratio for I-131, Tl-201, and Tc-99m-MIBI was more than 10. The sensitivity of the mediastinum was appropriate, except for I-131 before ablation, and the sensitivity of the lung before and after ablation was inferior for either tracer. The speciﬁcity of the cervix for I-131 before ablation was markedly deteriorated, but it increased after ablation.
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T he standard therapy for diﬀerentiated thyroid cancer is surgical resection followed by radioiodine (I-131)ablation［1］. Despite this eﬀective treatment, the overall recurrence rate of thyroid cancer is 20［2］. Apart from the growth of metastases from
 
diﬀerentiated thyroid cancer, which is comparatively slow and passes without symptom, discovery is often late and thus therapeutic time is lost［3］.
Conventional imaging modalities used for surveillance include CT (computed tomography) for detecting lung metastases, MRI (magnetic resonance imaging)for brain lesions, and ultrasonography for cervical nodal metas-
tases. However, radioisotopic examination is comparable
［1］, and I-131 scanning (I-131)is indispensable for the
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management of patients with diﬀerentiated thyroid cancer
［4］.
Serum thyroglobulin (Tg)is a glycoprotein 660,000 Daltons in size that is normally sequestrated in the follicles of the thyroid gland and plays a central role in the synthesis and storage of thyroid hormones［5］. Patients with diﬀerentiated thyroid cancer are followed up after thyroidectomy by serial Tg estimation and I-131 whole body scanning［6, 7］. Even if their Tg level increases,
I-131 does not accumulate, and therefore the other diagnostic method is indispensable［8］.
The accumulation of Tl-201 in lung cancer,malignant lymphoma, and parathyroid tumor other than diﬀerentiated thyroid cancer as a tracer for oncoscintigra-
phy as well as myocardial scintigraphy depends on blood ﬂow and Na?-K?-ATPase［9-11］. On the other hand,
the accumulation of Tc-99m-MIBI (hexakis-2-methoxy-
isobutyl-isonitrile) reﬂects mitochondrial metabolism
［12］, but Tc-99m MIBI atypically accumulates in the metastatic lesions of thyroid cancer［9］. In the case of a high level of Tg and negative I-131, Tl-201 and Tc-99m-
MIBI scintigraphy is better［13］. More than 50  of cases for which I-131 was normal are positive for Tl-201 and Tc-99m-MIBI［14］. However, they confused before ablation cases with after ablation cases for I-131.
A consensus has not yet been obtained regarding the detectability of systemic metastatic lesions of diﬀerentiated thyroid cancer by I-131, Tl-201, and Tc-99m-MIBI before and after ablation, as reported by Dadparvar
［15］. Furthermore, the diagnostic capability for all sites before and after ablation of I-131 has not been reported on. Therefore, we compared the diagnostic capabilities of I-131, Tl-201, and Tc-99m-MIBI scintigrams of the entire body and all loci before and after ablation.
Materials and Methods
 
Our subjects were patients with diﬀerentiated thyroid cancer after total thyroidectomy and I-131 therapy had been performed in our institute from August, 1999 to June, 2003. There were 36 patients treated a total of 64 times. They consisted of 17 men and 19 women. Their ages ranged from 22 to 75 years, with an average of 60.5±12.3 years. The histopathological examinations performed were as follows:31 papillary carcinomas with 52 samples taken and 5 follicular carcinomas with 12 samples taken. We measured Tg before I-131 therapy during 3 weeks of iodine limitation. In addition, Tl-201,
Tc-99m-MIBI, and bone scintigraphy were performed during this period.
Based on several reports［3,9,16,17］, we deﬁned the cases as metastatic when TSH (thyroid stimulating hormone)was greater than or equal to 50μU/ml and Tg
(immunoradiometric assay, less than 35 ng/ml)was more than 30 ng/ml, or when TSH was less than 50μU/ml and Tg was more than 10 ng/ml, or we were able to prove the lesions on CT, MRI or bone scintigram.
The number of metastatic regions totaled 69, includ-
ing 12 regions in the cervix, 41 regions in the lung, 6 regions in the mediastinum, 7 regions in the bone, and 3 regions in the meninx.
Tl-201 and Tc-99m-MIBI scintigraphy was performed using a double-headed gamma camera (7200A/DI, 9300A/DI, Toshiba, Tokyo,
Japan)ﬁtted with a low-energy parallel hole collimator.
Brieﬂy, planar images were obtained 5 min after intra-
venous administration of 74 MBq of Tl-201 or 555 MBq of Tc-99m-MIBI. SPECT (single photon emission computed tomography)images were then obtained 20 min later. The energy setting was 70 keV±10 for Tl-201 and 140 keV ±10  for Tc-99m-MIBI. Images were acquired on a 64×64 pixel matrix with 60 angular steps over 360 degrees at 30 sec per step. The data was reconstructed utilizing a Butterworth preﬁlter and ﬁltered backprojection with a Ramp ﬁlter.
For I-131 scintigraphy, the patients orally received 3.7-5.55 GBq??I-Na, and most scintigraphy was perfor-
med 48 h later, except for 1 case for whom scintigraphy was performed 7 days later. Planar images were obtained by means of a double-headed gamma camera(7200A/DI,
9300A/DI, Toshiba, Tokyo, Japan)with a medium-
energy parallel hole collimator, where the energy setting was at 364 keV±10 .
We deﬁned ablation for the ﬁrst time as before ablation and ablation after the second time as after ablation. We also divided the body into 5 areas:cervix, lung, medias-
tinum, bone, and other. If there was a deﬁnite accumula-
tion in one place in each part, as with metastasis or recurrence, we deﬁned it as being increased accumulation.
Regarding accumulation in the 64 cases, 3 kinds of scintigram, I-131, Tl-201, and Tc-99m-MIBI, were visually interpreted.We deﬁned the case for accumulation being equal or lower than the background as no accumula-
tion, and accumulation being higher than the background as increased accumulation. All images were interpreted by 3 consultants, including 2 nuclear specialists, by consen-
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sus.
To evaluate diagnostic capabilities, we calculated the sensitivity, speciﬁcity, and positive and negative likelihood ratios.
The positive and nega-
tive likelihood ratios were the index for which the number of metastatic cases was taken to be the numerator and the number of non-metastatic cases the denominator, among positive or negative cases, respectively. The positive likelihood ratio was considered to be signiﬁcant for values above 10, and the negative likelihood ratio was considered to be signiﬁcant for values under 0.1. We used χ?
analysis for diagnostic capabilities of each tracer for the entire body before and after ablation. A P value of less than 0.05 was considered statistically signiﬁcant.
Results
 
For the entire body before ablation, the sensitivity and speciﬁcity were slightly high for Tl-201 and Tc-99m-
MIBI in comparison with I-131. Tl-201 was the highest for the positive likelihood ratio, with a value of 14. For the negative likelihood ratio, Tl-201 and Tc-99m-MIBI were less than 0.1, but I-131 was 0.14(Table 1).
For the entire body after ablation, the sensitivity of I-131 increased and the sensitivity of Tl-201 and Tc-99m-
MIBI decreased. The speciﬁcity of both tracers was high,
and no diﬀerences were observed. The positive likelihood ratio was found to be more than 10 for both tracers.
However, the negative likelihood ratio was not less than 0.1 for either of them(Table 2).
The speciﬁcity of I-131 was statistically signiﬁcant
(P＜0.05)before and after ablation(Table 3).
The sensitivity and speciﬁcity before and after ablation
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Table 3  Results of diagnostic studies before and after I-131 ablation for patients with thyroid carcinoma
 
Sensitivity(%) Speciﬁcity(%)
I-131  Tl-201  Tc-99m-MIBI  I-131  Tl-201  Tc-99m-MIBI
 
before ablation  38  56  56  84  99  98 after ablation  61  47  44  98  99  99 P  0.108  0.285  0.212  0.0000313? 0.478  0.614
?P＜0.05, χ?test
 
Table 1  Results of postoperative diagnostic studies before I-131 ablation for patients with thyroid carcinoma
 
I-131  Tl-201  Tc-99m-MIBI
 
TP  9  14  14 TN  106  124  122 FP  20  1  3 FN  15  11  11 (region)??
Sensitivity(%) 38  56  56 Speciﬁcity(%) 84  99  98 LR(＋) 0.45  14.00  4.67 LR(－) 0.14  0.09  0.09
 
TP, true-positive;TN, true-negative;FP, false-positive;FN, false-
negative;LR(＋), positive likelihood ratio;LR(－), negative likeli-
hood ratio.
?LR＋values of 10 or greater and LR-values of 0.1 or smaller are consistent with a test with considerable diagnostic value.
??metastatic regions were divided into 5 areas:neck, lung, medias-
tinum, bone, and other.
Table 2  Results of diagnostic studies after I-131 ablation for patients with thyroid carcinoma
 
I-131  Tl-201  Tc-99m-MIBI
 
TP  28  21  20 TN  122  124  124 FP  2  1  1 FN  18  24  25 (region)??
Sensitivity(%) 61  47  44 Speciﬁcity(%) 98  99  99 LR(＋) 14.0  21.0  20.0 LR(－) 0.14  0.19  0.20
 
TP, true-positive;TN, true-negative;FP, false-positive;FN, false-
negative;LR(＋), positive likelihood ratio;LR(－), negative likeli-
hood ratio.
?LR＋values of 10 or greater and LR-values of 0.1 or smaller are consistent with a test with considerable diagnostic value.
??metastatic regions were divided into 5 areas:neck, lung, medias-
tinum, bone, and other.
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for the scintigram of each region are shown in Table 4.
For the cervical region, lymph node metastasis before ablation occurred in 5 cases (local recurrence:1 case),
and lymph node metastasis after ablation occurred in 7
(local recurrence:1 case). The sensitivity decreased slightly for both tracers before and after ablation. For Tl-201 and Tc-99m-MIBI, the sensitivity was appropriate in comparison with I-131 before and after ablation, while the speciﬁcity was appropriate except for I-131 before ablation.
For the lung, the sensitivity of each scintigram was less than 50 , but the speciﬁcity was 100  for all scintigrams.
For the mediastinum, there was no accumulation of I-131 for 2 cases before ablation. However, for all 4 cases after ablation, the accumulation was present. The sensitivity levels of Tl-201 and Tc-99m-MIBI were 100
, but the speciﬁcity was not. For before ablation, a false-positive was observed for one Tl-201 case and two Tc-99m-MIBI cases, and for after ablation one Tl-201 case and one Tc-99m-MIBI case were observed. In all cases the tracer seemed to be accumulated in the blood pool.
For the bones, the sensitivity of I-131 was 100 before and after ablation, but the sensitivity of Tl-201 and
 
Tc-99m-MIBI was 40  after ablation and decreased before and after ablation. The speciﬁcity was appropriate before and after ablation. For I-131, 1 false-positive case was observed after ablation.
For meningeal metastases, all tracers were observed before ablation. For 2 cases I-131 was observed after ablation, but for Tl-201 and Tc-99m-MIBI the sensitivity decreased. The speciﬁcity was appropriate for all tracers.
There was almost complete agreement between the results with Tl-201 and Tc-99m-MIBI before and after ablation. However, for Tc-99m-MIBI there were many false-positives in comparison with Tl-201, and the posi-
tive likelihood ratio was low before ablation.
Among the cases examined, 1 was a 66-year-old woman with a tumor diagnosed as local recurrent papillary cancer before ablation, where her Tg was 470 ng/ml
(Fig. 1A). The accumulation of I-131 was not observable in the tumor because of its accumulation in the thyroid bed
(Fig. 1B). However,we did observe increased accumula-
tion of Tl-201(Fig. 1 C)and Tc-99m-MIBI (Fig. 1D).
Another case was that of a 67-year-old woman with right 8th rib metastasis from follicular carcinoma after ablation, for whom the Tg was 13.2 ng/ml(Fig. 2A). A Tc-99m-HMDP (hydroxymethylene diphosphonate)bone scintigram showed decreased accumulation in her right 8th
 
Table 4  Sensitivity and speciﬁcity before and after ablation of scintigraphy for various sites
 
Position  Nuclide  
Sensitivity(%)
Before(n＝30) After(n＝34)
Speciﬁcity(%)
Before(n＝30) After(n＝34)
I-131  60.0(3/5) 57.1(4/7) 20.8(5/24) 100 (27/27)
Cervix  Tl-201  100 (5/5) 85.7(6/7) 100 (24/24) 100 (27/27)
MIBI  80.0(4/5) 71.4(5/7) 95.8(23/24) 100 (27/27)
I-131  21.4(3/14) 44.4(12/27) 100 (16/16) 100 (7/7)
Lung  Tl-201  35.7(5/14) 33.3( 9/27) 100 (16/16) 100 (7/7)
MIBI  35.7(5/14) 29.6(8/27) 100 (16/16) 100 (7/7)
I-131  0 (0/2) 100 (4/4) 100 (28/28) 100 (30/30)
Mediastinum  Tl-201  100 (2/2) 100 (4/4) 96.4(27/28) 96.7(29/30)
MIBI  100 (2/2) 100 (4/4) 92.9 (26/28) 96.7(29/30)
I-131  100 (2/2) 100 (5/5) 100 (28/28) 96.6(28/29)
Bone  Tl-201  50 (1/2) 40 (2/5) 100 (28/28) 100 (29/29)
MIBI  100 (2/2) 40 (2/5) 100 (28/28) 100 (29/29)
I-131  100 (1/1) 100 (2/2) 100 (29/29) 100 (32/32)
Others  Tl-201  100 (1/1) 0 (0/2) 100 (29/29) 100 (32/32)
MIBI  100 (1/1) 50 (1/2) 100 (29/29) 100 (32/32)
?The number of metastatic regions totaled 69.
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 rib, and this was diagnosed as bone metastasis(Fig. 2B).
Tl-201 and Tc-99m-MIBI showed no accumulation in the right 8th rib (Fig. 2D, Fig. 2E), but I-131 showed increased accumulation in the rib(Fig. 2 C).
Discussion
 
We studied the diagnostic capabilities of nuclear medicine examinations with respect to metastatic foci for
 
diﬀerentiated thyroid carcinoma of the entire body and all sites before and after ablation. For the entire body,
Tl-201 and Tc-99m-MIBI were found to be appropriate diagnostic tracers before ablation, and I-131 was found to be appropriate after ablation. This is because I-131 has lower sensitivity and speciﬁcity and positive likelihood ratio than Tl-201 and Tc-99m-MIBI, and because Tl-201 and Tc-99m-MIBI are superior to I-131 regarding their negative and positive likelihood ratios. For Tl-201, the
 
Fig.1  Images from Case 1, a 66-year-old woman who had a tumor diagnosed as papillary carcinoma with local recurrence and multiple lung metastases. A local recurrent mass was noted by CT(arrow)A. ??I accumulated in the thyroid bed B, but a??Tl scintigram C and a
??Tc-MIBI scintigram D showed more prominent and extensive uptake in accordance with a local recurrent mass.
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 Fig.2  Images from Case 2, a 67-year-old woman with rt. 8th rib metastasis from follicular carcinoma. An osteolytic lesion was noted by CT(arrow)A. A??Tc-HMDP bone scintigram showed a bone lesion at the rt. 8th rib(arrow)B. A??I scintigram showed extensive uptake in accordance with rt. 8th rib metastasis C. A??Tl scintigram D and a??Tc-MIBI scintigram E showed no uptake by the rt. 8th rib.
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positive likelihood ratio is at its highest at 14.
With regard to why the sensitivity of I-131 is low before ablation accumulating in the thyroid bed［18］, we believe that accumulation in the residual tumor and recur-
rent lesion is relatively decreased and can be overlooked.
On the other hand, although the sensitivity of I-131 increases for the entire body after ablation, the sensitivity of Tl-201 and Tc-99m-MIBI deteriorates. Our results diﬀered from a report by Dadparvar in which the sensitiv-
ity of I-131 rose after ablation［15］.
It has been reported that the sensitivity of I-131 is 47-
84 and its speciﬁcity is 96-99 ［5, 9］, but all reports show mixed results for before and after ablation. We found good speciﬁcity similar to that described in previous reports, but the sensitivity before ablation was low at 38
, and the sensitivity after ablation also tended to be low at 61 . The reason why the sensitivity after ablation rose appears to be that the accumulation for residual tumors or recurrent lesions is relatively increased.
Regarding the reason why the sensitivity before and after ablation was low, in most cases there is a period of２
days before imaging by I-131 administration, as reported by Okuyama et al.［18］, to allow for insuﬃcient washing of the background. It is possible that we could not conﬁrm I-131 accumulation in small lesions.
In our study, both before and after ablation, the sensitivity and speciﬁcity of Tl-201 and Tc-99m-MIBI were observed to be within the ranges noted on previous studies, which reported that the sensitivity of Tl-201 is 45-94 ［16］and its speciﬁcity is 82-97 ［19］, while the sensitivity of Tc-99m-MIBI is 36-100 ［5, 9, 20］
and its speciﬁcity is 89-94 ［5, 9, 20］. However,
compared with before ablation, the sensitivity after abla-
tion deteriorated. We thought that the causes were the degradation of metabolism, blood ﬂow degradation, and a disorder of the cell membrane due to thyroid gland tissue dysfunction. The reason is that the accumulation of Tc-99m-MIBI reﬂects mitochondrial metabolism［12］,
and the accumulation of Tl-201 depends on blood ﬂow and Na?-K?-ATPase［9］.
We could not ﬁnd a report that divided every section into before and after ablation for I-131, over the range that we examined. In our study, the sensitivity was observed to be less than 50  for all tracers and the positive rate of lung metastases was lower in comparison with a report which found that is 82 for I-131, 55 for Tl-201, and 46 for Tc-99m-MIBI［9］. The lungs are the most common site for distant metastases of
 
diﬀerentiated thyroid carcinoma［21］. The low sensitivity of I-131 and Tl-201 in lung metastases for identifying lesions of 1 mm by CT in comparison with bone metas-
tases and lymph node metastases probably occurs because it is hard to detect aberrant accumulation by radioisotope examination for which the spatial resolution is inferior
［18］. It was diﬃcult to ﬁnd lung metastases for Tl-201,
due to the low energy and degradation of the imaging and contrast due to scattered radiation［22］.
It is desirable to use both I-131 and Tl-201 for the metastatic foci, except in the case of lung metastases,
instead of only using I-131［23］. These techniques are eﬀective for searching before ablation for metastatic lesions other than lung metastases. We investigated the diagnostic capabilities for the cervical region and medias-
tinal lymph nodes and found that Tl-201 and Tc-99m-
MIBI were superior tracers. For the cervical region, in our study the speciﬁcity before ablation for I-131 was poor, because I-131 accumulates in the thyroid bed even in cases without metastases or recurrence. In the cervical region, the cervical echo examination［1］or combination Tl-201 scintigraphy can be used jointly to check for cervical metastases.
It was reported that the positive rate of metastatic lymph node detection including for the cervix and medias-
tinum is 78  by I-131, 39  by Tl-201, and 56  by Tc-99m-MIBI［9］, and Tc-99m-MIBI is superior for detection in comparison with I-131［17, 24］. We believe there were false-positive cases in Tl-201 and Tc-99m-
MIBI for mediastinal lymph nodes because of atypical accumulation(so-called blood pooling)in the mediastinum due to a secretion, a leakage, or an inﬂammation.
For thyroid cancer with bone metastasis, the progno-
sis is poor and the 10-year survival rate is less than 20
［25］. In addition, the sensitivity of bone scintigraphy to bone metastatic lesions is low, and the retrieval of bone metastasis by the optimum nuclide is generally required.
There is a bulletin assuming that Tl-201 and Tc-99m-
MIBI may be better than I-131 for detecting bone metastasis［18, 26］, but we found that the detection capabilities of I-131 are appropriate.
With respect to the diagnostic capability of Tl-201 and Tc-99m-MIBI in comparison with detectability, better performance is achieved using Tc-99m-MIBI than Tl-201
［27-29］. However, in our study, Tl-201 performed well, although large discrepancies were noted as mentioned in reports by Reynolds and Seabold［14, 30］.
Tc-99m-MIBI was inferior to Tl-201 due to the high
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occurrence of false-positive results. We expect improve-
ments in diagnostic capabilities when Tl-201 is used before ablation.
Our study had some limitations. The ﬁrst limitation is that because before and after ablation there is little cases to examine every site, we cannot conclusively comment about the utility of this examination. The second limita-
tion is that we could only make a conﬁrmation of lung metastasis by CT examination and not by nuclear medi-
cine examination. However, it seems that there are few cases such as ours reported in the literature. The third limitation is that this was not a complete prospective study. The cases after the second therapy for which ablation was performed more than twice were included in our report. Thus, we cannot make a comparison before and after ablation purely using threshold values that we found.
In the future, PET (positron emission tomography)
systems may be prevalent. However, at institutions without access to PET, we can expect improvements in the detection of recurrence and metastasis after total thyroidectomy using I-131 and Tl-201 as complements to each other.
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